Canopy Growth shares rise 10.93% after-hours on U.S. marijuana rescheduling news.

Canopy Growth surged 10.93% in after-hours trading, driven by reports that U.S. President Donald Trump plans to reschedule marijuana from Schedule I to Schedule III, easing regulatory and banking hurdles for cannabis businesses. This development, first highlighted in pre-market sessions and reiterated in after-hours updates, aligns with earlier gains seen in cannabis stocks like Tilray and the MSOS ETF. While product launches (e.g., Claybourne Gassers vapes and Australian softgel expansions) and improved liquidity metrics were cited in prior reports, the immediate catalyst for the after-hours jump was the anticipated policy shift, which could boost demand for Canopy’s products and tax advantages. Financial challenges, including negative profit margins and debt, remain but were overshadowed by optimism around regulatory progress.